Drugs / Autologous epidermal cell suspension
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03162367 | Apr 2019 → Mar 2020 | — | SCARM Institute, Tabriz, Iran | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous epidermal cell suspension | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03162367 ↗ |